Image
Insights
In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.
Image
FDA Oncology Trial Guidance Targets Eligibility Barriers
Image
EHR Patient Recruitment Gets A Reality Check
Image
Could q-CAR Redefine Drug Discovery?
Drug Discovery
Image
Throne Science: Passive Health Monitoring in the Bathroom
Data and Digital Health
Image
Data Integrity and ALCOA Principles in Pharma Manufacturing
ALCOA
Image
FDA Generic Peptides Guidance Sets New Expectations
Peptides and Obesity Treatments
Explore All Insights
Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.
Robotics and GMP: Building the Factory of Tomorrow
Robotics in pharmaceutical manufacturing is strengthening GMP through automation, contamination control, traceability, and more consistent production processes.
FDA Oncology Trial Guidance Targets Eligibility Barriers
FDA oncology clinical trial guidance targets restrictive eligibility criteria, covering performance status, washout periods, medications, and laboratory values.
EHR Patient Recruitment Gets A Reality Check
EHR patient recruitment could improve clinical trial matching, but workflow integration, data quality, interoperability, and AI validation remain key challenges.
Could q-CAR Redefine Drug Discovery?
Find out how q-CAR drug discovery moves beyond static protein structures by linking protein dynamics, ligand activity, and AI to precision drug design.
Throne Science: Passive Health Monitoring in the Bathroom
Read about how Throne Science is advancing passive health monitoring with AI-powered sensing that automatically captures daily toilet habit data.
Data Integrity and ALCOA Principles in Pharma Manufacturing
Data integrity and ALCOA principles are under new pressure as digital twins, AI, and continuous manufacturing reshape pharma production and quality control.
FDA Generic Peptides Guidance Sets New Expectations
Revised FDA draft guidance for generic peptide products updates expectations for ANDAs, impurities, structure, immune response, and biological activity.
Cold Chain Optimisation by Rethinking Pharma Logistics
See how cold chain optimisation can reduce pharmaceutical logistics costs, emissions, and product risk by modelling uncertainty across storage and distribution.
The Ethics of Decentralised Clinical Trials
Ethical obligations in decentralised clinical trials extend beyond consent and privacy. Sponsors must protect safety, scientific validity, equity, and oversight.
Nanocarriers Target the Eye for Better Ocular Drug Delivery
Ocular drug delivery faces major biological barriers. Nanocarriers could improve bioavailability, tissue targeting, controlled release, and treatment for difficult eye diseases.
AI Creates New Viruses? Not Quite. AI-Designed Bacteriophages
AI-designed bacteriophages show how genome models could create new antibacterial therapies while forcing pharma to rethink biological AI governance and biosecurity.
What is a Continuous Improvement Mindset in Pharma Manufacturing?
A continuous improvement mindset strengthens pharma manufacturing quality. See how quality management and CGMP inspections can sustain continuous improvement.
